Marker Screening
1 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| Proteomics/Modifier Based on Mass Spectrometry Reveals the Pathogenesis of Eclampsia During Pregnancy and the Screening of Disease Markers (NCT04833881) | Heilongjiang University of Chinese Medicine | 2021-04-01 |
Track Marker Screening automatically
Every clearance here is in the API, with alerts when new ones post.